Submitted by: Submitted by oliviaaarkstore
Views: 10
Words: 2226
Pages: 9
Category: Business and Industry
Date Submitted: 07/27/2016 12:27 AM
China Oral Antihyperglycemic Drugs Market Research Report to 2020
The diabetes market is estimated to reach over $60 billion a year. And Oral Antihyperglycemic Drugs share over 60% of the market. As the world’s most populous country, China has 11.6% diabetes mellitus patients among adult’s populations, which make China the most potential region of diabetes market.
This report studies Oral Antihyperglycemic Drugs in China market, covering USA, Canada and Mexico, focuses on top players in three Regions, with sales, price, revenue and market share in China market, like
Eli Lilly
AstraZeneca
Bayer
Takeda
Novo Nordisk
Pfizer
Sinofi
Boehringer-Ingelheim
Hansoh Pharma
Huadong Medicine
Luye Pharma
Hengrui Pharmaceutical
Tipr Pharmaceutical
Pku Healthcare
Jiangsu Heng Rui Medicine
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Sensitizers
Secretagogues
Alpha-glucosidase inhibitors
DPP-4 inhibitors
You can order full Report @ http://www.aarkstore.com/medical-devices/210070/china-oral-antihyperglycemic-drugs-market-research-report-to-2020
Table of Content
1 Oral Antihyperglycemic Drugs Overview
1.1 Product Overview and Scope of Oral Antihyperglycemic Drugs
1.2 Oral Antihyperglycemic Drugs Segment by Type
1.2.1 Sensitizers and Sales Growth Rate 2011-2020
1.2.2 Secretagogues and Sales Growth Rate 2011-2020
1.2.3 Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020
1.2.4 DPP-4 inhibitors and Sales Growth Rate 2011-2020
1.3 Oral Antihyperglycemic Drugs Segment by Population Age
1.3.1 Oral Antihyperglycemic Drugs Sales Market Share by Population Age in 2015 and 2016
1.4 Oral Antihyperglycemic Drugs Market by Regions
1.5 China Market Size (Value and Volume) of Oral Antihyperglycemic Drugs 2011-2020
1.5.1 China Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020
1.5.2 China Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020
2 China...